Navigation Links
Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Date:3/8/2012

sfunction (FSD) is a multi-factorial condition that has anatomical, physiological, medical, psychological and social components. FSD includes four disorders: hypoactive sexual desire disorder, female sexual arousal disorder, sexual pain disorder and orgasmic disorder. To establish a diagnosis of FSD, one or more of these disorders must be associated with personal distress, as determined by the affected women. Approximately 40 million American women are affected by FSD. The National Health and Social Life Survey, a probability sample study of sexual behavior in a demographically representative cohort of United States adults ages 18 to 59, found that approximately 43% of women suffer from some form of FSD, with up to about 15% having associated personal distress required to establish a diagnosis of FSD.

There are no drugs in the United States approved for FSD indications.

Bremelanotide for Sexual Dysfunction

Palatin is developing subcutaneously administered bremelanotide for the treatment of FSD in premenopausal women in patients non-responsive to current therapies. Bremelanotide, which is a melanocortin agonist (a compound which binds to a cell receptor and triggers a response) drug candidate, is a synthetic peptide analog of the naturally occurring hormone alpha-MSH (melanocyte-stimulating hormone).

About Palatin Technologies

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com

Forward-looking Statements

Statements in this pres
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
11. Palatin Technologies to Present at 9th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
(Date:5/5/2015)... EXTON, Pa. , May 5, 2015  The ... global leader in pharmacokinetic testing of drugs and safety ... Gum , Associate Director of Preclinical Studies, presented at ... in Vision and Ophthalmology (ARVO) in Denver, ... presentation was "Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable ...
(Date:5/5/2015)... 2015  American Laboratory Trading, Inc. (ALT), the leading ... industry veteran Anggie Becorest as their new ... based out of the company,s San Diego ... the company,s west coast operations, diversifying the company,s offerings, ... has been the leader in the refurbished lab equipment ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3ALT Names Anggie Becorest Senior Vice President of Business Development 2
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... ( Optimity) will present at the ... 20 at 1:15 p.m. MT in Scottsdale, AZ. ... the nation’s leading nonprofit authority on the use ... information exchange. Donald Graf, National Director of Telemedicine ...
(Date:5/5/2015)... From the halls of Microsoft ... in enabling enterprise collaboration across platforms and devices, ... up and simplify the move to Microsoft Office ... for Office 365 enable organizations to migrate ... user adoption and effectively managing critical business data ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great conditions last ... walkers participated in Global Lyme Alliance’s (GLA) inaugural “Lyme ... 5K and 10K runs and 1-and 3-mile walks were held ... for tick-borne disease research. The “Lyme Walk and Run” was ... of Lyme Research Alliance (LRA) and Tick-Borne Disease Alliance (TBDA), ...
(Date:5/5/2015)... QuickPick Travel ” was featured on NewsWatch as part of ... and large businesses making an impact in their industry. Susan ... the business review and shared with viewers how this is ... vacation for free. , Vacations are a sought-after opportunity to ... when people are preparing for vacations, they’re used to getting ...
(Date:5/5/2015)... Information Innovators Inc. (“Triple-i”), ... government, today announced its acquisition of Creative ... exclusively to federal government customers through its highly ... health services, and program management support. The company ... a Third Party Assessment Organization (3PAO) for cloud ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... 21 As a new year,approaches, the American Society ... 50 and over to add getting screened for,colorectal cancer ... Recent,studies have confirmed that a majority of Americans who ... is a preventable and,treatable disease when caught in its ...
... NEWPORT BEACH, Calif., Dec. 21 When men leave ... of care and,treatment. More often than not, a spouse ... often lacks the information and confidence,necessary to provide all ... being under more stress than the patient., Laurel ...
... December 21, 2007 The American Society ... role of endoscopy in treating dyspepsia, discomfort thought to ... of the population in Western countries. An upper ... evaluate the inside of the esophagus, stomach and small ...
... interferon almost doubled patients, time without disease progression, ... -- A combination treatment with two drugs, Avastin ... with kidney cancer, European researchers report. , "Based ... already considerable enthusiasm to use bevacizumab as a ...
... Warwick, Edinburgh, Dundee and the Czech Republics Institute of ... is up to 80 times more powerful than other ... to kill cancer cells in much more targeted ... as trans, trans, trans- [Pt(N3)2(OH)2(NH3)(py)], or a light ...
... focus On Software & Software Services Yields Two ... Genstar Capital, LLC, a middle,market private equity firm ... sciences, healthcare services, industrial technology, software and,software services, ... a,Managing Director., "We have been extremely pleased ...
Cached Medicine News:Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 2Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 3Health News:Helping Couples Fight Prostate Cancer, This Week on Your Cancer Today(TM) 2Health News:ASGE offers guidelines on endoscopic treatment of dyspepsia 2Health News:ASGE offers guidelines on endoscopic treatment of dyspepsia 3Health News:New Combo Treatment Extends Kidney Cancer Survival 2Health News:Light powered platinum more targeted and 80 times more powerful than similar cancer treatments 2Health News:Genstar Capital Appoints Mark Hanson to Managing Director 2
... and quantitative evaluation of pancreatic -cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... assess -cell function because of the large and ...
... kit is an enzymeimmunoassay for the quantitation ... in serum or plasma. Calibrators, controls and ... D. The diluted samples are incubated in ... highly specific sheep 25-OH D antibody for ...
... responsible for the control of glucose metabolism. ... islets of Langerhans as the precursor, proinsulin, which ... Both are secreted in equimolar amounts into the ... comprised of two polypeptide chains, the A-chain and ...
... (ACE) is an integral part of the ... Angiotensin II as well as the degradation ... types, ACE is primarily located in endothelial ... diagnostic parameter for sarcoidosis and myocardial infarction ...
Medicine Products: